SGLT2 inhibitors attenuate nephrin loss and enhance TGF-ß<sub>1</sub> secretion in type 2 diabetes patients with albuminuria: a randomized clinical trial.

Tian, Yuan; Chen, Xiao-Min; Liang, Xian-Ming; Wu, Xiao-Bin; Yao, Chun-Meng

SGLT2 inhibitors attenuate nephrin loss and enhance TGF-ß₁ secretion in type 2 diabetes patients with albuminuria: a randomized clinical trial.

Tian, Yuan; Chen, Xiao-Min; Liang, Xian-Ming; Wu, Xiao-Bin; Yao, Chun-Meng.

Affiliation

Tian Y; Department of Endocrinology and Metabolism, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, 201-209 Hubin South Road, Xiamen, 361004, People's Republic of China.
Chen XM; Department of Endocrinology and Metabolism, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, 201-209 Hubin South Road, Xiamen, 361004, People's Republic of China. chenxiaomin0517@sina.com.
Liang XM; Center of Clinical Laboratory, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, 201-209 Hubin South Road, Xiamen, 361004, People's Republic of China.
Wu XB; Department of Endocrinology and Metabolism, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, 201-209 Hubin South Road, Xiamen, 361004, People's Republic of China.
Yao CM; Department of Nephrology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, 201-209 Hubin South Road, Xiamen, 361004, People's Republic of China.

Sci Rep ; 12(1): 15695, 2022 Sep 20.

Article in En | MEDLINE | ID: mdl-36127497

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / Kidney Diseases Type of study: Clinical_trials Limits: Humans Language: En Journal: Sci Rep Year: 2022 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google